Package-Ref? Lung Cancer SHOX2/PTGER4/RASSF1A for Methylation control
CBPE0206
詢 價
索取COA
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| Introduction | ||||||
| Description | DNA methylation is an epigenetic modification, a form of chemical modification of DNA, which refers to the carbon 5 of cytosine in the genomic CpG dinucleotide under the action of DNA methyltransferase. covalently bonded to a methyl group. It can change genetic expression without changing the DNA sequence. This package contains multiple detection samples for Lung cancer, We use simulated clinical cell lines to prepare them. If you are testing SHOX2/PTGER4/RASSF1A, you can choose this product. |
|||||
| Technical Data | ||||||
| Classification | Cat No. | Name | Description | Region | Methylation level | |
| 質控品 | CBPE0206-1 | 肺癌-SHOX2,PTGER4,RASSF1A陽性甲基化 | SHOX2 Methylation Positive control | chr3:157821337-157821430(hg19) | 97.43% | |
| PTGER4 Methylation Positive control | chr5:40681482-40681593(hg19) | 99.76% | ||||
| PTGER4 Methylation Positive control | chr5:40681898-40682110(hg19) | 96.26% | ||||
| RASSF1A Methylation Positive control | chr3:50378322-50378233(hg19) | 99.33% | ||||
| CBPE0206-2 | 肺癌-SHOX2,PTGER4,RASSF1A陰性甲基化 | SHOX2 Methylation Negative control | chr3:157821337-157821430(hg19) | 0.00% | ||
| PTGER4 Methylation Negative control | chr5:40681482-40681593(hg19) | 0.19% | ||||
| PTGER4 Methylation Negative control | chr5:40681898-40682110(hg19) | 0.05% | ||||
| RASSF1A Methylation Negative control | chr3:50378322-50378233(hg19) | 0.02% | ||||
| CBPE0206-3 | 肺癌-PTGER4強陽性甲基化，SHOX2陰性甲基化,RASSF1A陰性甲基化 | SHOX2 Methylation Negative control | chr3:157821337-157821430(hg19) | 0.12% | ||
| PTGER4 Methylation Positive control | chr5:40681482-40681593(hg19) | 79.25% | ||||
| PTGER4 Methylation Positive control | chr5:40681898-40682110(hg19) | 84.78% | ||||
| RASSF1A Methylation Negative control | chr3:50378322-50378233(hg19) | 0.00% | ||||
| CBPE0206-4 | 肺癌-SHOX2,PTGER4陰性甲基化，RASSF1A陽性甲基化 | SHOX2 Methylation Negative control | chr3:157821337-157821430(hg19) | 0.12% | ||
| PTGER4 Methylation Negative control | chr5:40681482-40681593(hg19) | 0.54% | ||||
| PTGER4 Methylation Negative control | chr5:40681898-40682110(hg19) | 0.00% | ||||
| RASSF1A Methylation Positive control | chr3:50378322-50378233(hg19) | 81.66% | ||||
| CBPE0206-5 | 肺癌-RASSF1A,PTGER4陰性甲基化，SHOX2陽性甲基化 | SHOX2 Methylation Positive control | chr3:157821337-157821430(hg19) | 50.32% | ||
| PTGER4 Methylation Negative control | chr5:40681482-40681593(hg19) | 0.78% | ||||
| PTGER4 Methylation Negative control | chr5:40681898-40682110(hg19) | 0.40% | ||||
| RASSF1A Methylation Negative control | chr3:50378322-50378233(hg19) | 0.00% | ||||
| Classification | Cat No. | Name | Description | Region | Methylation level | |
| 單陽SHOX2-參考品 | 單陽SHOX2區(qū)段-強陽性參考品-1 | CBPE0206-6 | SHOX2強陽性甲基化參考品，RASSF1A,PTGER4陰性甲基化 | SHOX2 Methylation Reference Standard with 50.00% | chr3:157821337-157821430 (hg19) | 50.32% |
| PTGER4 Methylation Negative Reference Standard | chr5:40681482-40681593 (hg19) | 0.78% | ||||
| PTGER4 Methylation Negative Reference Standard | chr5:40681898-40682110 (hg19) | 0.40% | ||||
| RASSF1A Methylation Negative Reference Standard | chr3:50378322-50378233 (hg19) | 0.00% | ||||
| 單陽SHOX2區(qū)段-強陽性參考品-2 | CBPE0206-7 | SHOX2強陽性甲基化參考品，RASSF1A,PTGER4陰性甲基化 | SHOX2 Methylation Reference Standard with 10.00% | chr3:157821337-157821430 (hg19) | 9.44% | |
| PTGER4 Methylation Negative Reference Standard | chr5:40681482-40681593 (hg19) | 0.00% | ||||
| PTGER4 Methylation Negative Reference Standard | chr5:40681898-40682110 (hg19) | 0.00% | ||||
| RASSF1A Methylation Negative Reference Standard | chr3:50378322-50378233 (hg19) | 0.00% | ||||
| 單陽SHOX2區(qū)段-弱陽性參考品 | CBPE0206-8 | SHOX2弱陽性甲基化參考品，RASSF1A,PTGER4陰性甲基化 | SHOX2 Methylation Reference Standard with 3.00% | chr3:157821337-157821430 (hg19) | N/A | |
| PTGER4 Methylation Negative Reference Standard | chr5:40681482-40681593 (hg19) | N/A | ||||
| PTGER4 Methylation Negative Reference Standard | chr5:40681898-40682110 (hg19) | N/A | ||||
| RASSF1A Methylation Negative Reference Standard | chr3:50378322-50378233 (hg19) | N/A | ||||
| 單陽SHOX2區(qū)段-檢測限參考品 | CBPE0206-9 | SHOX2檢測限甲基化參考品，RASSF1A,PTGER4陰性甲基化 | SHOX2 Methylation Reference Standard with 1.00% | chr3:157821337-157821430 (hg19) | 1.57% | |
| PTGER4 Methylation Negative Reference Standard | chr5:40681482-40681593 (hg19) | 0.30% | ||||
| PTGER4 Methylation Negative Reference Standard | chr5:40681898-40682110 (hg19) | 0.79% | ||||
| RASSF1A Methylation Negative Reference Standard | chr3:50378322-50378233 (hg19) | 0.00% | ||||
| 單陽SHOX2區(qū)段-陰性參考品 | CBPE0206-10 | SHOX2陰性甲基化參考品，RASSF1A,PTGER4陰性甲基化 | SHOX2 Methylation Negative Reference Standard | chr3:157821337-157821430 (hg19) | 0.00% | |
| PTGER4 Methylation Negative Reference Standard | chr5:40681482-40681593 (hg19) | 0.19% | ||||
| PTGER4 Methylation Negative Reference Standard | chr5:40681898-40682110 (hg19) | 0.05% | ||||
| RASSF1A Methylation Negative Reference Standard | chr3:50378322-50378233 (hg19) | 0.02% | ||||
| 單陽SHOX2區(qū)段-精密度參考品 | CBPE0206-11 | SHOX2弱陽性甲基化參考品，RASSF1A,PTGER4陰性甲基化 | SHOX2 Methylation Reference Standard with 3.00% | chr3:157821337-157821430 (hg19) | N/A | |
| PTGER4 Methylation Negative Reference Standard | chr5:40681482-40681593 (hg19) | N/A | ||||
| PTGER4 Methylation Negative Reference Standard | chr5:40681898-40682110 (hg19) | N/A | ||||
| RASSF1A Methylation Negative Reference Standard | chr3:50378322-50378233 (hg19) | N/A | ||||
| CBPE0206-12 | SHOX2陰性甲基化參考品，RASSF1A,PTGER4陰性甲基化 | SHOX2 Methylation Negative Reference Standard | chr3:157821337-157821430 (hg19) | 0.00% | ||
| PTGER4 Methylation Negative Reference Standard | chr5:40681482-40681593 (hg19) | 0.19% | ||||
| PTGER4 Methylation Negative Reference Standard | chr5:40681898-40682110 (hg19) | 0.05% | ||||
| RASSF1A Methylation Negative Reference Standard | chr3:50378322-50378233 (hg19) | 0.02% | ||||
| Classification | Cat No. | Name | Description | Region | Methylation level | |
| 單陽PTGER4-參考品 | 單陽PTGER4區(qū)段-強陽性參考品-1 | CBPE0206-13 | PTGER4強陽性甲基化參考品，SHOX2陰性甲基化，RASSF1A陰性甲基化 | PTGER4 Methylation Reference Standard with 75.00% | chr5:40681482-40681593 (hg19) | 79.25% |
| PTGER4 Methylation Reference Standard with 80.00% | chr5:40681898-40682110 (hg19) | 84.78% | ||||
| RASSF1A Methylation Negative Reference Standard | chr3:50378322-50378233 (hg19) | 0.00% | ||||
| SHOX2 Methylation Negative Reference Standard | chr3:157821337-157821430 (hg19) | 0.12% | ||||
| 單陽PTGER4區(qū)段-強陽性參考品-2 | CBPE0206-14 | PTGER4強陽性甲基化參考品，RASSF1A,SHOX2陰性甲基化 | PTGER4 Methylation Reference Standard with 10.00% | chr5:40681482-40681593 (hg19) | 11.17% | |
| PTGER4 Methylation Reference Standard with 10.00% | chr5:40681898-40682110 (hg19) | 11.33% | ||||
| RASSF1A Methylation Negative Reference Standard | chr3:50378322-50378233 (hg19) | 0.21% | ||||
| SHOX2 Methylation Negative Reference Standard | chr3:157821337-157821430 (hg19) | 0.08% | ||||
| 單陽PTGER4區(qū)段-弱陽性參考品 | CBPE0206-15 | PTGER4弱陽性甲基化參考品，RASSF1A,SHOX2陰性甲基化 | PTGER4 Methylation Reference Standard with 3.00% | chr5:40681482-40681593 (hg19) | N/A | |
| PTGER4 Methylation Reference Standard with 3.00% | chr5:40681898-40682110 (hg19) | N/A | ||||
| RASSF1A Methylation Negative Reference Standard | chr3:50378322-50378233 (hg19) | N/A | ||||
| SHOX2 Methylation Negative Reference Standard | chr3:157821337-157821430 (hg19) | N/A | ||||
| 單陽PTGER4區(qū)段-檢測限參考品 | CBPE0206-16 | PTGER4檢測限甲基化參考品，RASSF1A,SHOX2陰性甲基化 | PTGER4 Methylation Reference Standard with 1.00% | chr5:40681482-40681593 (hg19) | 1.30% | |
| PTGER4 Methylation Reference Standard with 1.00% | chr5:40681898-40682110 (hg19) | 2.35% | ||||
| RASSF1A Methylation Negative Reference Standard | chr3:50378322-50378233 (hg19) | 0.00% | ||||
| SHOX2 Methylation Negative Reference Standard | chr3:157821337-157821430 (hg19) | 0.18% | ||||
| 單陽PTGER4區(qū)段-陰性參考品 | CBPE0206-17 | PTGER4陰性甲基化參考品，RASSF1A,SHOX2陰性甲基化 | PTGER4 Methylation Negative Reference Standard | chr5:40681482-40681593 (hg19) | 0.19% | |
| PTGER4 Methylation Negative Reference Standard | chr5:40681898-40682110 (hg19) | 0.05% | ||||
| RASSF1A Methylation Negative Reference Standard | chr3:50378322-50378233 (hg19) | 0.02% | ||||
| SHOX2 Methylation Negative Reference Standard | chr3:157821337-157821430 (hg19) | 0.00% | ||||
| 單陽PTGER4區(qū)段-精密度參考品 | CBPE0206-18 | PTGER4弱陽性甲基化參考品，RASSF1A,SHOX2陰性甲基化 | PTGER4 Methylation Reference Standard with 3.00% | chr5:40681482-40681593 (hg19) | N/A | |
| PTGER4 Methylation Negative Reference Standard | chr5:40681898-40682110 (hg19) | N/A | ||||
| RASSF1A Methylation Negative Reference Standard | chr3:50378322-50378233 (hg19) | N/A | ||||
| SHOX2 Methylation Negative Reference Standard | chr3:157821337-157821430 (hg19) | N/A | ||||
| CBPE0206-19 | PTGER4陰性甲基化參考品，RASSF1A,SHOX2陰性甲基化 | PTGER4 Methylation Negative Reference Standard | chr5:40681482-40681593 (hg19) | 0.19% | ||
| PTGER4 Methylation Negative Reference Standard | chr5:40681898-40682110 (hg19) | 0.05% | ||||
| RASSF1A Methylation Negative Reference Standard | chr3:50378322-50378233 (hg19) | 0.02% | ||||
| SHOX2 Methylation Negative Reference Standard | chr3:157821337-157821430 (hg19) | 0.00% | ||||
| Classification | Cat No. | Name | Description | Region | Methylation level | |
| 單陽RASSF1A-參考品 | 單陽RASSF1A區(qū)段-強陽性參考品-1 | CBPE0206-20 | RASSF1A強陽性甲基化參考品，PTGER4,SHOX2陰性甲基化 | RASSF1A Methylation Reference Standard with 80.00% | chr3:50378322-50378233 (hg19) | 81.66% |
| PTGER4 Methylation Negative Reference Standard | chr5:40681482-40681593 (hg19) | 0.54% | ||||
| PTGER4 Methylation Negative Reference Standard | chr5:40681898-40682110 (hg19) | 0.00% | ||||
| SHOX2 Methylation Negative Reference Standard | chr3:157821337-157821430 (hg19) | 0.12% | ||||
| 單陽RASSF1A區(qū)段-強陽性參考品-2 | CBPE0206-21 | RASSF1A強陽性甲基化參考品，PTGER4,SHOX2陰性甲基化 | RASSF1A Methylation Reference Standard with 10.00% | chr3:50378322-50378233 (hg19) | N/A | |
| PTGER4 Methylation Negative Reference Standard | chr5:40681482-40681593 (hg19) | N/A | ||||
| PTGER4 Methylation Negative Reference Standard | chr5:40681898-40682110 (hg19) | N/A | ||||
| SHOX2 Methylation Negative Reference Standard | chr3:157821337-157821430 (hg19) | N/A | ||||
| 單陽RASSF1A區(qū)段-弱陽性參考品 | CBPE0206-22 | RASSF1A弱陽性甲基化參考品，PTGER4,SHOX2陰性甲基化 | RASSF1A Methylation Reference Standard with 3.00% | chr3:50378322-50378233 (hg19) | N/A | |
| PTGER4 Methylation Negative Reference Standard | chr5:40681482-40681593 (hg19) | N/A | ||||
| PTGER4 Methylation Negative Reference Standard | chr5:40681898-40682110 (hg19) | N/A | ||||
| SHOX2 Methylation Negative Reference Standard | chr3:157821337-157821430 (hg19) | N/A | ||||
| 單陽RASSF1A區(qū)段-檢測限參考品 | CBPE0206-23 | RASSF1A檢測限甲基化參考品，PTGER4,SHOX2陰性甲基化 | RASSF1A Methylation Reference Standard with 1.00% | chr3:50378322-50378233 (hg19) | N/A | |
| PTGER4 Methylation Negative Reference Standard | chr5:40681482-40681593 (hg19) | N/A | ||||
| PTGER4 Methylation Negative Reference Standard | chr5:40681898-40682110 (hg19) | N/A | ||||
| SHOX2 Methylation Negative Reference Standard | chr3:157821337-157821430 (hg19) | N/A | ||||
| 單陽RASSF1A區(qū)段-陰性參考品 | CBPE0206-24 | RASSF1A陰性甲基化參考品，PTGER4,SHOX2陰性甲基化 | RASSF1A Methylation Negative Reference Standard | chr3:50378322-50378233 (hg19) | 0.02% | |
| PTGER4 Methylation Negative Reference Standard | chr5:40681482-40681593 (hg19) | 0.19% | ||||
| PTGER4 Methylation Negative Reference Standard | chr5:40681898-40682110 (hg19) | 0.05% | ||||
| SHOX2 Methylation Negative Reference Standard | chr3:157821337-157821430 (hg19) | 0.00% | ||||
| 單陽RASSF1A區(qū)段-精密度參考品 | CBPE0206-25 | RASSF1A弱陽性甲基化參考品，PTGER4,SHOX2陰性甲基化 | RASSF1A Methylation Reference Standard with 3.00% | chr3:50378322-50378233 (hg19) | N/A | |
| PTGER4 Methylation Negative Reference Standard | chr5:40681482-40681593 (hg19) | N/A | ||||
| PTGER4 Methylation Negative Reference Standard | chr5:40681898-40682110 (hg19) | N/A | ||||
| SHOX2 Methylation Negative Reference Standard | chr3:157821337-157821430 (hg19) | N/A | ||||
| CBPE0206-26 | RASSF1A4陰性甲基化參考品，PTGER4,SHOX2陰性甲基化 | RASSF1A Methylation Negative Reference Standard | chr3:50378322-50378233 (hg19) | 0.02% | ||
| PTGER4 Methylation Negative Reference Standard | chr5:40681482-40681593 (hg19) | 0.19% | ||||
| PTGER4 Methylation Negative Reference Standard | chr5:40681898-40682110 (hg19) | 0.05% | ||||
| SHOX2 Methylation Negative Reference Standard | chr3:157821337-157821430 (hg19) | 0.00% | ||||
| 備注 | 1. 質控品也叫準確度標準品，用于定性判斷； 2. 參考品用于定性和定量的判斷，其中強陽、弱陽、檢測限、精密度、特異性的判定需要視具體項目而定，本產(chǎn)品的判定僅為內部標準； 3. 質控品用于性能評價，出廠檢，試劑盒日常檢測判定，參考品用于性能評價，出廠檢； 4.上述產(chǎn)品只展示了部分結果，甲基化程度可以定制。 |
|||||
| Product Information | ||||||
| Intended Use | Research Use Only | |||||
| Concentration | Download for COA | |||||
| Purity | Download for COA | |||||
| DNA electrophoresis | Download for COA | |||||
| Format | Genomic DNA | |||||
| Unit Size | 1ug | |||||
| Storage | 4°C | |||||
| Expiry | 36 months from the date of manufacture | |||||
| Remark | The data in the instruction manual is the data of a single test, and the specific data of each batch is subject to delivery. | |||||
